Table 2 Clinical data at time of CT and thermodilution measurement, respectively
From: Aortic volume determines global end-diastolic volume measured by transpulmonary thermodilution
All | Female patients | Male patients | |
|---|---|---|---|
n (%) | 103 (100) | 38 (36.9) | 65 (63.1) |
ICU scoring | |||
APACHE II | 26 (21–31) | 27 (20–32) | 25 (22–30) |
SAPS II | 56 (45–67) | 54 (43–63) | 58 (46–68) |
SOFA | 11 (9–13) | 11 (9–14) | 11 (9–13) |
Patients receiving catecholamines, n (%) | |||
Adrenaline | 4 (3.9) | 1 (2.6) | 3 (4.6) |
Dobutamine | 7 (6.8) | 2 (5.3) | 5 (7.7) |
Norepinephrine | 101 (98.1) | 37 (97.4) | 64 (98.5) |
Norepinephrine dose at time of TD measurement, μg/kg/min | 0.27 (0.11–0.52) | 0.32 (0.12–0.53) | 0.20 (0.11–0.47) |
Norepinephrine dose at time of CT, μg/kg/min | 0.26 (0.11–0.50) | 0.30 (0.11–0.51) | 0.25 (0.11–0.50) |
Patients receiving another cardiovascular agent, n (%) | |||
Enoximone | 10 (9.7) | 3 (7.9) | 7 (10.8) |
Nitroglycerine | 3 (2.9) | 2 (5.3) | 1 (1.5) |
Vasopressin | 2 (1.9) | 1 (2.6) | 1 (1.5) |
Patients receiving more than one cardiovascular agent, n (%) | 21 (20.4) | 7 (18.4) | 14 (21.5) |
Parameters of mechanical ventilation at time of thermodilution measurement | |||
PEEP, mmHg | 10 (9–13) | 10 (9–12) | 10 (9–13) |
f, 1/min | 21 (18–25) | 20 (17–24) | 22 (18–26) |
VT, l | 0.49 (0.40–0.55) | 0.41 (0.33–0.49) | 0.51 (0.46–0.57) |
Parameters of mechanical ventilation at time of CT | |||
PEEP, mmHg | 10 (9–13) | 10 (9–13) | 11 (9–13) |
f, 1/min | 21 (17–25) | 21 (17–25) | 22 (18–25) |
VT, l | 0.49 (0.40–0.55) | 0.40 (0.36–0.49) | 0.52 (0.46–0.56) |
Time span between CT and thermodilution measurement, hours | 1 (-1–3) | 0 (-1–3) | 1 (-1–3) |
Fluid balance between CT and thermodilution measurement, ml | -10 (-198–258) | 0 (-94–434) | -31 (-289–128) |
Continuous veno-venous hemodialysis, n (%) | 20 (19.4) | 6 (15.8) | 14 (21.5) |
CVC position | |||
V. jugularis, n (%) | 48 (46.6) | 20 (52.6) | 28 (43.1) |
V. subclavia, n (%) | 40 (38.8) | 13 (34.2) | 27 (41.5) |
V. femoralis, n (%) | 15 (14.6) | 5 (13.2) | 10 (15.4) |
Aortic aneurysm, n (%) | 2 (1.9) | 0 (0) | 2 (3.1) |
Status post-OAR or EVAR, n (%) | 5 (4.9) | 0 (0) | 5 (7.7) |